Mutations in the human 5-lipoxygenase gene

Clinical Reviews in Allergy and Immunology

Volumn 17, Issue 1-2, 1999, Pages 59-69

  In, Kwang Ho ^a   Silverman, Eric S ^a   Asano, Koichiro ^a   Beier, David ^a   Fischer, Andrew R ^a   Keith, Tim P ^b   Serino, Kristina ^b   Yandava, Chandri ^a   De Sanctis, George T ^a   Drazen, Jeffrey M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GENOME THERAPEUTICS CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; LEUKOTRIENE; LEUKOTRIENE A4; PROTEIN;

ALLELE; BASE PAIRING; DELETION MUTANT; DNA FLANKING REGION; DNA POLYMORPHISM; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE MUTATION; GENE SEQUENCE; NUCLEIC ACID BASE SUBSTITUTION; PROTEIN EXPRESSION; REVIEW; SEQUENCE ANALYSIS;

EID: 0032800283     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02737597     Document Type: Review

References (14)

1. Samuelsson B. Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220:568-575.
2. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: Structures, biosynthesis, and biological effects. Science 1987;237:1171-1176.
3. Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry, and relation to pathobiology in human diseases. N Engl J Med 1990;323:645-655.
4. Funk CD, Hoshiko S, Matsumoto T, Radmark O, Samuelsson B. Characterization of the human 5-lipoxygenase gene. Proc Natl Acad Sci USA 1989;86:2587-2591.
5. Hoshiko S, Radmark O, Samuelsson B. Characterization of the human 5-lipoxygenase gene promoter. Proc Natl Acad Sci USA 1990;87:9073-9077.
6. Carter GW, Young PR, Albert DH, IBouska J, Dyer R, Bell RL, et al. 5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 1991;256:929-937.
7. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB, et al. Monteleukast: A once daily leukotriene receptor antagonist in the treatment of chronic asthma. Arch Int Med 1998;158:1213-1220.
8. Liu MC, Dube LM, Lancaster J. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial. J Allerg Clin Immunol 1996;98:859-871.
9. DuBuske LM, Grossman J, Dube L, S,wanson L, Lancaster J, The Zileuton Study Group. Randomized trial of zileuton in patients with moderate asthma: Effect of reduced dosing frequency and amounts on pulmonary function and asthma symptoms. Am J Managed Care 1997;3:633-640.
10. Sugden B, Mark W. Clonal transformation of adult human leukocytes by Epstein-Barr virus. J Virol 1977;23:503-508.
11. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 1986;73:320-326.
12. In KH, Asano K, Beier D, Grobholz J, Finn PW, Silverman EK, et al. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription. J Clin Invest 1997;99:1130-1137.
13. Finn PW, Kara CJ, Douhan J, Van TT, Folsom V, Glimcher LH. Interferon gamma regulates binding of two nuclear protein complexes in a macrophage cell line. Proc Natl Acad Sci USA 1990;87:914-918.
14. Ausubel FM, Brent R, Kingston RE, Seidman JG, Smith JA, Stuhl K. Current Protocols in Molecular Biology. Wiley, New York, 1993.